Press release Read more about Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production
Press release Read more about Disclosure of transactions in own shares from July 01st to July 05th, 2024
Press release Read more about AXA: Information relating to the number of voting rights and shares making up the share capital on 30/06/2024